Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
173 studies found for:    Open Studies | "Drug Interactions"
Show Display Options
Rank Status Study
21 Recruiting Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.
Condition: Healthy
Interventions: Drug: Dicloxacillin;   Drug: Placebos
22 Recruiting Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris
Conditions: Tinea Pedis;   Tinea Cruris
Intervention: Drug: Omeprazole 40mg
23 Not yet recruiting Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
Condition: Type 2 Diabetes
Intervention: Drug: Evogliptin, Pioglitazone, Evogliptin+Pioglitazone
24 Not yet recruiting Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg
Condition: Type2 Diabetes
Interventions: Drug: Evogliptin→Evogliptin+Glimepiride→Glimepiride;   Drug: Glimepiride→Evogliptin→Evogliptin+Glimepiride
25 Recruiting A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors
Condition: cMET-dysregulated Advanced Solid Tumors
Interventions: Drug: INC280;   Drug: digoxin;   Drug: rosuvastatin
26 Recruiting A Study to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
Condition: Epilepsy
Interventions: Drug: GWP42003-P;   Drug: Placebo
27 Recruiting Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally
Condition: Fungal Infection
Interventions: Drug: APX001 single IV dose;   Drug: APX001 single oral dose 1;   Drug: APX001 single oral dose 2;   Drug: APX001 single oral dose 3;   Drug: APX001 single oral dose fasted;   Drug: APX001 single oral dose fed;   Drug: APX001 multiple oral doses 1;   Drug: APX001 multiple oral doses 2;   Drug: APX001 multiple oral doses 3;   Drug: Cytochrome P450 substrates;   Drug: Matching placebo control
28 Recruiting Study to Assess the Safety, Tolerability, PK, ECG Effects, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers
Condition: Healthy Volunteer
Interventions: Drug: PTI-428;   Other: Placebo;   Drug: ethinyl estradiol and levonorgestrel
29 Recruiting A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors
Condition: ALK-positive Advanced Tumors
Interventions: Drug: ceritinib;   Drug: warfarin;   Drug: midazolam
30 Recruiting A Primary Prevention Trial to Strengthen Child Attachment in a Native Community
Condition: Parent-child Interaction
Interventions: Behavioral: PFR Group;   Behavioral: Resource & Referral Group
31 Recruiting DHB Supplement Interaction Study
Condition: Healthy Volunteers
Intervention:
32 Recruiting Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections
Conditions: Arthritis, Infectious;   Bone Diseases, Infectious
Intervention: Drug: usual antibiotic treatment
33 Recruiting Dabigatran in an Interaction Probe Drug Cocktail
Condition: Healthy Volunteers
Interventions: Drug: Caffeine;   Drug: Diclofenac;   Drug: Esomeprazole;   Drug: Metoprolol;   Drug: Midazolam;   Drug: Dabigatran;   Drug: Clarithromycin
34 Recruiting A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sotagliflozin (SAR439954);   Drug: midazolam;   Drug: metoprolol
35 Recruiting Study of Potential for Interaction of Fluconazole With F901318
Condition: Invasive Aspergillosis
Interventions: Drug: F901318;   Drug: Fluconazole
36 Not yet recruiting Gene-virus Interactions Implicated in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Genetic: Enterovirus vaccination
37 Recruiting Social Interactions: Ocular Explorations and Pupillometry in Autism
Condition: Autism Spectrum Disorders
Intervention:
38 Recruiting Cilostazol-Simvastatin Drug Interaction Study
Conditions: Dyslipidemias;   Peripheral Artery Disease
Interventions: Drug: Simvastatin;   Drug: Pravastatin;   Drug: Cilostazol
39 Recruiting Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan
Condition: Endometriosis
Interventions: Drug: Rifampicin;   Drug: Midazolam;   Drug: BAY1002670_Vilaprisan
40 Recruiting Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
Conditions: Cytochrome P450 CYP2D6 Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   CYP2D6 Polymorphism
Interventions: Genetic: Pharmacogenetic testing;   Other: Software-based drug & gene interaction risk analysis;   Other: MTM

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.